> Detailanzeige

Joos, Stefan; Nettelbeck, Dirk M.; Reil‐Held, Anette; Engelmann, Katja; Moosmann, Alexandra; Eggert, Angelika; Hiddemann, Wolfgang; Krause, Mechthild; Peters, Christoph; Schuler, Martin; Schulze‐Osthoff, Klaus; Serve, Hubert; Wick, Wolfgang; Puchta, Josef; Baumann, Michael

German Cancer Consortium (DKTK) – A national consortium for translational cancer research

Literatur-
verwaltung

Zur
Merkliste

Lösche von
Merkliste

Per Whatsapp teilen

Schließen

Merkliste



Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
  • Medientyp: E-Artikel
  • Titel: German Cancer Consortium (DKTK) – A national consortium for translational cancer research
  • Beteiligte: Joos, Stefan; Nettelbeck, Dirk M.; Reil‐Held, Anette; Engelmann, Katja; Moosmann, Alexandra; Eggert, Angelika; Hiddemann, Wolfgang; Krause, Mechthild; Peters, Christoph; Schuler, Martin; Schulze‐Osthoff, Klaus; Serve, Hubert; Wick, Wolfgang; Puchta, Josef; Baumann, Michael
  • Erschienen: Wiley, 2019
  • Erschienen in: Molecular Oncology, 13 (2019) 3, Seite 535-542
  • Sprache: Englisch
  • DOI: 10.1002/1878-0261.12430
  • ISSN: 1574-7891; 1878-0261
  • Schlagwörter: Cancer Research ; Genetics ; Molecular Medicine ; General Medicine ; Oncology
  • Entstehung:
  • Hochschulschrift:
  • Anmerkungen:
  • Beschreibung: <jats:p>The German Cancer Consortium (‘Deutsches Konsortium für Translationale Krebsforschung’, <jats:styled-content style="fixed-case">DKTK</jats:styled-content>) is a long‐term cancer consortium, bringing together the German Cancer Research Center (<jats:styled-content style="fixed-case">DKFZ</jats:styled-content>), Germany's largest life science research center, and the leading University Medical Center‐based Comprehensive Cancer Centers (<jats:styled-content style="fixed-case">CCC</jats:styled-content>s) at seven sites across Germany. <jats:styled-content style="fixed-case">DKTK</jats:styled-content> was founded in 2012 following international peer review and has positioned itself since then as the leading network for translational cancer research in Germany. <jats:styled-content style="fixed-case">DKTK</jats:styled-content> is long term funded by the German Ministry of Research and Education and the federal states of each <jats:styled-content style="fixed-case">DKTK</jats:styled-content> partner site. <jats:styled-content style="fixed-case">DKTK</jats:styled-content> acts at the interface between basic and clinical cancer research, one major focus being to generate suitable multisite cooperation structures and provide the basis for including higher numbers of patients and facilitate effective collaborative forward and reverse translational cancer research. The consortium addresses areas of high scientific and medical relevance and develops critical infrastructures, for example, for omics technologies, clinical and research big data exchange and analysis, imaging, and clinical grade drug manufacturing. Moreover, <jats:styled-content style="fixed-case">DKTK</jats:styled-content> provides a very attractive environment for interdisciplinary and interinstitutional training and career development for clinician and medical scientists.</jats:p>
  • Zugangsstatus: Freier Zugang